US2023145207A1PendingUtilityA1

Pharmaceutical compositions comprising poh derivatives and methods of use

71
Assignee: NEONC TECH INCPriority: Apr 19, 2017Filed: Jan 6, 2023Published: May 11, 2023
Est. expiryApr 19, 2037(~10.8 yrs left)· nominal 20-yr term from priority
A61K 31/20A61K 9/0048A61K 9/0043A61K 45/06A61K 47/55A61P 35/00A61K 31/045
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of a perillyl alcohol derivative such as a perillyl alcohol ester, or an isoperillyl alcohol derivative such as an isoperillyl alcohol ester. The derivative may be a perillyl alcohol or an isoperillyl alcohol conjugated with a therapeutic agent such as valproic acid. The route of administration may vary, including inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating a disease in a mammal, the method comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol conjugated with valproic acid. 
     
     
         2 . The method of  claim 1 , wherein the disease is cancer. 
     
     
         3 . The method of  claim 2 , wherein the cancer is a tumor of the nervous system. 
     
     
         4 . The method of  claim 3 , wherein the tumor is a glioblastoma. 
     
     
         5 . The method of  claim 1 , further comprising the step of treating the mammal with radiation. 
     
     
         6 . The method of  claim 1 , further comprising the step of administering to the mammal a chemotherapeutic agent. 
     
     
         7 . The method of  claim 1 , wherein the perillyl alcohol conjugated with valproic acid is administered by inhalation, intranasally, orally, intravenously, subcutaneously or intramuscularly. 
     
     
         8 . A method for treating a disease in a mammal, comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol conjugated with valproic acid conjugated with valproic acid using a nasal delivery device. 
     
     
         9 . The method of  claim 8 , wherein the nasal delivery device is selected from the group consisting of an intranasal inhaler, an intranasal spray device, an atomizer, a nebulizer, a metered dose inhaler (MDI), a pressurized dose inhaler, an insufflator, a unit dose container, a pump, a dropper, a squeeze bottle and a bi-directional device.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.